Exencial Wealth Advisors LLC Acquires 22,433 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Exencial Wealth Advisors LLC added 22,433 shares of Intuitive Surgical in the fourth quarter, boosting its stake to 23,244 shares — worth about $13.16 million per the latest 13F filing.
• The stock holds a consensus "Moderate Buy" rating with a consensus target of $581.91, and several firms recently updated views (e.g., Citigroup upgraded to Buy, Goldman raised its target, Jefferies trimmed its target).
• Intuitive beat recent estimates with EPS $2.50 vs. $2.08 and revenue $2.77B (up 23% year-over-year), while insiders sold 5,413 shares worth about $2.68M in the last quarter and now own 0.60% of the stock.

Exencial Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2,766.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,244 shares of the medical equipment provider's stock after acquiring an additional 22,433 shares during the period. Exencial Wealth Advisors LLC's holdings in Intuitive Surgical were worth $13,164,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of ISRG. Holos Integrated Wealth LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $25,000. Newbridge Financial Services Group Inc. grew its position in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 33 shares during the period. Greykasell Wealth Strategies Inc. bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $27,000. Olistico Wealth LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Finally, Caitlin John LLC bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $30,000. Institutional investors own 83.64% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on ISRG. Weiss Ratings reissued a "hold (c+)" rating on shares of Intuitive Surgical in a research report on Monday, December 29th. Citigroup raised shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and set a $590.00 price objective for the company in a research report on Wednesday, March 11th. Sanford C. Bernstein upped their target price on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an "outperform" rating in a report on Friday, January 23rd. The Goldman Sachs Group upped their target price on shares of Intuitive Surgical from $609.00 to $621.00 and gave the stock a "buy" rating in a report on Wednesday, April 22nd. Finally, Jefferies Financial Group dropped their target price on shares of Intuitive Surgical from $560.00 to $515.00 and set a "hold" rating for the company in a report on Wednesday, April 22nd. Eighteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $581.91.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 645 shares of the business's stock in a transaction on Monday, March 9th. The shares were sold at an average price of $485.01, for a total value of $312,831.45. Following the sale, the senior vice president owned 1,613 shares in the company, valued at $782,321.13. The trade was a 28.57% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 105 shares of the business's stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 5,413 shares of company stock worth $2,681,362 in the last quarter. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $470.99 on Tuesday. The company has a market capitalization of $166.81 billion, a P/E ratio of 57.09, a P/E/G ratio of 3.88 and a beta of 1.68. The company has a fifty day moving average of $477.17 and a 200 day moving average of $516.57. Intuitive Surgical, Inc. has a fifty-two week low of $427.84 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. The company had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. Intuitive Surgical's quarterly revenue was up 23.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.81 EPS. Analysts forecast that Intuitive Surgical, Inc. will post 8.51 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.